Dexcom | DXCM - Current Assets

Stock Price
61.57
Daily Change
-1.13 -1.80%
Monthly
-7.88%
Yearly
-14.08%
Q2 Forecast
60.25

Dexcom reported $4.03B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.74B 380M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
J&J USD 59.17B 3.55B Mar/2026
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Solventum Corp USD 3.86B 548M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
West Pharmaceutical Services USD 1.83B 151.4M Mar/2026
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025